| scholarly article | Q13442814 |
| P50 | author | Irene Pichler | Q30347710 |
| Andrew A Hicks | Q37389840 | ||
| P2093 | author name string | Peter P Pramstaller | |
| Alessandra Zanon | |||
| P2860 | cites work | Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation | Q73187402 |
| An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production | Q73192853 | ||
| Sequence analysis of the entire mitochondrial genome in Parkinson's disease | Q77577390 | ||
| Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls | Q88257756 | ||
| Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria | Q21563375 | ||
| Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 | ||
| PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease | Q24294809 | ||
| PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility | Q24296955 | ||
| PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 | Q24297155 | ||
| Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy | Q24300975 | ||
| LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1 | Q24301357 | ||
| The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy | Q24316726 | ||
| Parkin is recruited selectively to impaired mitochondria and promotes their autophagy | Q24317471 | ||
| PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons | Q24322788 | ||
| Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy | Q24339224 | ||
| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. | Q24634577 | ||
| Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress | Q27305291 | ||
| Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease | Q27686808 | ||
| Sequence and organization of the human mitochondrial genome | Q27860659 | ||
| CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study | Q28114901 | ||
| Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control | Q28114972 | ||
| Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle | Q28235835 | ||
| Mitochondrial dysfunction and oxidative damage in parkin-deficient mice | Q28593859 | ||
| Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy | Q29147504 | ||
| Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease | Q29398392 | ||
| Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin | Q29547423 | ||
| Mitochondrial respiratory-chain diseases | Q29614474 | ||
| Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 | ||
| Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin | Q29615623 | ||
| Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin | Q29615625 | ||
| Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants | Q29615627 | ||
| Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin | Q29615684 | ||
| High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease | Q29619113 | ||
| PINK1-dependent recruitment of Parkin to mitochondria in mitophagy | Q29620567 | ||
| Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin | Q29622838 | ||
| Epidemiology, environmental risk factors and genetics of Parkinson's disease. | Q30238483 | ||
| Genetics of Parkinson's disease. | Q30241723 | ||
| Postencephalitic parkinsonism--a review | Q30432015 | ||
| A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2 | Q30497782 | ||
| Environment, mitochondria, and Parkinson's disease | Q34133031 | ||
| PINK1 mutations are associated with sporadic early-onset parkinsonism | Q34345883 | ||
| A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease | Q34526685 | ||
| Mitochondrial DNA: impacting central and peripheral nervous systems | Q34737643 | ||
| Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms | Q34864555 | ||
| Gut microbiota are related to Parkinson's disease and clinical phenotype | Q35492461 | ||
| Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease | Q72964832 | ||
| SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila | Q47928029 | ||
| Point mutations of mitochondrial genome in Parkinson's disease | Q48075275 | ||
| Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria | Q48333081 | ||
| Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons | Q48588748 | ||
| Mitochondrial DNA polymorphism in substantia nigra | Q48844431 | ||
| CHCHD2 gene mutations in familial and sporadic Parkinson's disease | Q49100971 | ||
| Early-onset familial parkinsonism due to POLG mutations | Q50278596 | ||
| A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy | Q50493784 | ||
| Microbe-mitochondrion crosstalk and health: An emerging paradigm | Q51801047 | ||
| Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients | Q53321449 | ||
| Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease | Q64796856 | ||
| Epidemiology of Parkinson's disease. | Q67401761 | ||
| Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease | Q69356679 | ||
| Abnormalities of the electron transport chain in idiopathic Parkinson's disease | Q69361952 | ||
| ??? | Q64787295 | ||
| The role of environmental exposures in neurodegeneration and neurodegenerative diseases | Q35551001 | ||
| Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons | Q35611727 | ||
| Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons. | Q35852144 | ||
| Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo | Q35912064 | ||
| Elevated serum pesticide levels and risk of Parkinson disease | Q36060169 | ||
| Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease | Q36212145 | ||
| Somatic mtDNA variation is an important component of Parkinson's disease | Q36595656 | ||
| Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain | Q36727241 | ||
| Deciphering the role of heterozygous mutations in genes associated with parkinsonism | Q36854642 | ||
| Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease | Q37027318 | ||
| Mitochondria in the aetiology and pathogenesis of Parkinson's disease | Q37037953 | ||
| Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking | Q37219276 | ||
| Effects of the organochlorine pesticide methoxychlor on dopamine metabolites and transporters in the mouse brain. | Q37401337 | ||
| Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease | Q37434427 | ||
| Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains | Q37623036 | ||
| Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 | ||
| Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons | Q37715032 | ||
| A tale on animal models of Parkinson's disease | Q37882583 | ||
| What genetics tells us about the causes and mechanisms of Parkinson's disease | Q37947563 | ||
| Neurotoxin-based models of Parkinson's disease | Q37959729 | ||
| Mechanism of the neurotoxicity of MPTP. An update | Q38005808 | ||
| Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences | Q38021865 | ||
| Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene | Q38365994 | ||
| Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease | Q38726592 | ||
| Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson's Disease | Q38746811 | ||
| Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome | Q38962543 | ||
| Mutations of glucocerebrosidase gene and susceptibility to Parkinson's disease: An updated meta-analysis in a European population | Q40914689 | ||
| Mitochondrial complex I deficiency in Parkinson's disease | Q41821730 | ||
| PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival. | Q42321011 | ||
| Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats | Q42436464 | ||
| The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L. | Q45161551 | ||
| A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. | Q45963658 | ||
| Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease | Q46691979 | ||
| Methoxychlor inhibits brain mitochondrial respiration and increases hydrogen peroxide production and CREB phosphorylation | Q46715278 | ||
| Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. | Q46717380 | ||
| Pooled analysis of tobacco use and risk of Parkinson disease | Q46785257 | ||
| A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci. | Q47823702 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 8684906 | |
| P577 | publication date | 2018-03-07 | |
| P1433 | published in | Parkinson's disease | Q27723341 |
| P1476 | title | Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance. | |
| P478 | volume | 2018 |
| Q90121106 | Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases |
| Q61809108 | Potential Role of Mic60/Mitofilin in Parkinson's Disease |
| Q57026122 | Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes |
Search more.